Monkeypox virus A29L protein as the target for specific diagnosis and serological analysis
Applied Microbiology and Biotechnology · 2024
DOI: 10.1007/s00253-024-13361-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Applied Microbiology and Biotechnology, 2024. Verfasst von Chia-Yu Liang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemical Science and Technology, College of Life Science, National Taiwan University, Taipei, 106, Taiwan. Hauptthemen laut MEDLINE: Monkeypox virus, Antibodies, Monoclonal, Antibodies, Viral, Mpox, Monkeypox. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Council, National Taiwan University.
Abstract (Originalsprache)
The unexpected monkeypox (Mpox) outbreak has been reported in many non-endemic countries and regions since May 2022. The mutant strains of Mpox virus (MPXV) were found with higher infectivity and greater capability for sustained human-to-human transmission, posing a significant public health threat. MPXV A29L, a protein homolog of vaccinia virus (VACV) A27L, plays an important role in viral attachment to host cell membranes. Therefore, MPXV A29L is considered the diagnostic target and the potential vaccine candidate for eliciting neutralizing antibodies and protective immune responses. In response to the escalating Mpox outbreak, three monoclonal antibodies (mAbs) (2-9B, 3-8G, and 2-5H) targeting the different domains of MPXV A29L have been developed in the study. Among them, 2-5H is highly specific for MPXV A29L without exhibiting cross-reactivity with VACV A27L. The antibody pairing composed of 2-5H and 3-8G has been developed as the lateral flow immunochromatographic assay for specific detection of MPXV A29L. However, these three mAbs were unable to inhibit A29L binding to heparin column or prevent MPXV infection in the neutralization test assays. The results of the serological assays using the truncated A29L fragments as the antigens showed that the Mpox patient sera contained significantly lower levels of antibodies targeting the N-terminal 1–34 residues of A29L, suggesting that the N-terminal portion of A29L is less immunogenic upon natural infection. Key points • MAbs 2-9B, 3-8G, and 2-5H neither interrupted A29L binding to heparin nor neutralized MPXV. • The LFIA composed of 3-8G and 2-5H can specifically distinguish MPXV A29L from VACV A27L. • Mpox patient sera contained lower levels of antibodies targeting the N-terminal portion of A29L.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemical Science and Technology, College of Life Science, National Taiwan University, Taipei, 106, Taiwan.
- Department of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei, 100, Taiwan.
- Department of Internal Medicine, College of Medicine, National Taiwan University Hospital, National Taiwan University, Taipei, 100, Taiwan.
- Department of Medicine, National Taiwan University Cancer Center, Taipei 106, Taiwan.
- Department of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei, 100, Taiwan. sychang@ntu.edu.tw.
- Department of Laboratory Medicine, College of Medicine, National Taiwan University Hospital, National Taiwan University, Taipei, 100, Taiwan. sychang@ntu.edu.tw.
Förderung
- National Science and Technology Council
- National Taiwan University
Zitieren
APA
Liang, C. Y., Chao, T. L., Chao, C. S., Liu, W. D., Cheng, Y. C., Chang, S. Y., & Chang, S. C. (2024). Monkeypox virus A29L protein as the target for specific diagnosis and serological analysis. Applied Microbiology and Biotechnology. https://doi.org/10.1007/s00253-024-13361-6
Vancouver
Liang CY, Chao TL, Chao CS, Liu WD, Cheng YC, Chang SY, et al. Monkeypox virus A29L protein as the target for specific diagnosis and serological analysis. Applied Microbiology and Biotechnology. 2024. doi:10.1007/s00253-024-13361-6
BibTeX
@article{Liang2024,
author = {Liang, Chia-Yu and Chao, Tai-Ling and Chao, Chong-Syun and Liu, Wang-Da and Cheng, Yu-Chen and Chang, Sui-Yuan and Chang, Shih-Chung},
title = {Monkeypox virus A29L protein as the target for specific diagnosis and serological analysis},
journal = {Applied Microbiology and Biotechnology},
year = {2024},
doi = {10.1007/s00253-024-13361-6}
}
EUVIMED